Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: A systematic review

Pediatric Allergy and Immunology

Volumn 19, Issue 3, 2008, Pages 197-207

  Röder, Esther ^a   Berger, Marjolein Y ^a   De Groot, Hans ^a   Van Wijk, Roy Gerth ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adolescent; Allergic rhinitis; Child; Immunotherapy; Randomized controlled trials; Systematic review

Indexed keywords

IMMUNOMODULATING AGENT; PLACEBO;

ADOLESCENT; ADULT; ANAPHYLAXIS; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFICACY; HAY FEVER; HUMAN; IMMUNOTHERAPY; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ALLERGENS; CHILD; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; UNITED STATES;

EID: 41149092695     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2007.00648.x     Document Type: Review

References (50)

1. Bousquet J, Lockey RF, Malling H-J. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998 : 53 (Suppl. 44 1 42.
2. Durham SR, Walker SM, Varga E-M, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999 : 341 : 468 75.
3. Möller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002 : 109 : 251 6.
4. Des Roches A, Paradis L, Menardo J-L, Bouges S, Daurés J-P, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract VI: specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997 : 99 : 450 3.
5. Bernstein DI, Wanner M, Borish L, Liss GM, The Immunotherapy Committee of the American Academy of Allergy, Asthma and Immunology. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol 2004 : 113 : 1129 36.
6. Robinson KA, Dickersin K. Development of a high sensitive search strategy for the retrieval of reports of controlled trials using PubMed. Int J Epidemiol 2002 : 31 : 150 3.
7. Verhagen AP, De Vet HCW, De Bie RA, et al. The Delphi List: a criteria list of quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998 : 51 : 1235 41.
8. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960 : 20 : 37 46.
9. Malling H-J. Immunotherapy as an effective tool in allergy treatment. Allergy 1998 : 53 : 461 72.
10. Van Tulder M, Furlan A, Bombardier C, Bouter L, The Editorial Board of the Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine 2003 : 28 : 1290 9.
11. Sanders S. The treatment of seasonal hay fever and asthma in children. A controlled trial of pre-seasonal depot pollen therapy. Practitioner 1966 : 196 : 811 5.
12. Fontana VJ, Holt LE Jr., Mainland D. Effectiveness of hyposensitization therapy in ragweed hay-fever in children. JAMA 1966 : 195 : 985 92.
13. Weisnagel J. Nouvel agent hyposensibilisant dans le traitement de la rhinite allergique saisonnière (fièvre des foins) à l'herbe à poux chez l'enfant: le MRTA (modified ragweed tyrosine adsorbate). Union Med Can 1979 : 108 : 685 90.
14. Dreborg S, Agrell B, Foucard T, Kjellman N-IM, Koivikko A, Nilsson S. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I Clinical results. Allergy 1986 : 41 : 131 40.
15. Urbanek R, Behrle M, Kuhn W. Die problematik der hausstaubmilbenallergie. Pädiatr Pädol 1991 : 26 : 25 30.
16. Bardare M, Zani G, Novembre E, Vierucci A. Local nasal immunotherapy with a powder extract for grass pollen induced rhinitis in pediatric ages: a controlled study. J Invest Allergol Clin Immunol 1996 : 6 : 359 63.
17. Mehta SB, Smith JM. Nasal hyposensitization and hay fever. Clin Allergy 1975 : 5 : 279 84.
18. Cserháti E, Mezei G. Nasal immunotherapy in pollen-sensitive children. Allergy 1997 : 52 (Suppl. 33 40 4.
19. Marcucci F, Sensi LG, Caffarelli C, et al. Low-dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides. Allergy 2002 : 57 : 23 8.
20. Caffarelli C, Sensi LG, Marcucci F, Cavagni G. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial. Allergy 2000 : 55 : 1142 7.
21. Urbanek R, Bürgelin KH, Kahle S, Kuhn W, Wahn U. Oral immunotherapy with grass pollen in enterosoluble capsules. Eur J Pediatr 1990 : 149 : 545 50.
22. Cooper PJ, Darbyshire J, Nunn AJ, Warner JO. A controlled trial of oral hyposensitization in pollen asthma and rhinitis in children. Clin Allergy 1984 : 14 : 541 50.
23. Reinert M, Reinert U. Orale hyposensibilisierung mit pollen- und plazebolösung. Prax Klin Pneumol 1983 : 37 : 228 31.
24. Möller C, Dreborg S, Lanner A, Björkstén B. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. Allergy 1986 : 41 : 271 9.
25. Giovane AL, Bardare M, Passalacqua G, et al. A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients. Clin Exp Allergy 1994 : 24 : 53 9.
26. Urbanek R, Gehl R. Wirksamkeit oraler hyposensibilisierung bei hausstaubmilbenallergie. Monatsschr Kinderheilkd 1982 : 130 : 150 2.
27. Bufe A, Ziegler-Kirbach E, Stoeckmann E, et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004 : 59 : 498 504.
28. Rolinck-Werninghaus C, Wolf H, Liebke C, et al. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004 : 59 : 1285 93.
29. Yuksel H, Tanac R, Gousseinov A, Demir E. Sublingual immunotherapy and influence on urinary leukotrienes in seasonal pediatric allergy. Invest Allergol Clin Immunol 1999 : 9 : 305 13.
30. Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004 : 114 : 851 7.
31. La Rosa M, Ranno C, André C, Carat F, Tosca MA, Canonica GW. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999 : 104 : 425 32.
32. Pajno GB, Vita D, Parmiani S, Caminiti L, La Grutta S, Barberio G. Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate. Clin Exp Allergy 2003 : 33 : 1641 7.
33. Vourdas D, Syrigou E, Potamianou P, et al. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 1998 : 53 : 662 72.
34. Ippoliti F, De Santes W, Volterrani A, et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003 : 14 : 216 21.
35. Bahçeciler NN, Işik U, Barlan IB, Başaran MM. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol 2001 : 32 : 49 55.
36. Hirsch TH, Sähn M, Leupold W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D. pt.) in children. Pediatr Allergy Immunol 1997 : 8 : 21 7.
37. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol et Immunopathol 1990 : 18 : 277 84.
38. Malling H-J. Is sublingual immunotherapy clinically effective? Curr Opin Allergy Clin Immunol 2002 : 2 : 523 31.
39. Sopo SM, Macchiaiolo M, Zorzi G, Tripodi S. Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature. Arch Dis Child 2004 : 89 : 620 4.
40. Passalacqua G, Guerra L, Pasquali M, Lombardi C, Canonica GW. Efficacy and safety of sublingual immunotherapy. Ann Allergy Asthma Immunol 2004 : 93 : 3 12.
41. Cox LS, Linnemann DL, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006 : 117 : 1021 35.
42. Penagos M, Compalati E, Tarantini F, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo controlled, double-blind trials. Ann Allergy Asthma Immunol 2006 : 97 : 141 8.
43. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996 : 276 : 637 9.
44. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998 : 352 : 609 13.
45. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. 2006. Available at: http://www.cochrane.org/resources/ handbook/index.htm (last accessed 6 October 2006).
46. Valovirta E, Jacobsen L, Ljørring C, Koivikko A, Savolainen J. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 2006 : 61 : 1177 83.
47. Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003 : 2 : CD002893.
48. Olaguibel JM, Álvarez Puebla MJ. Efficacy of sublingual allergen vaccination for respiratory allergen in children. Conclusions from one meta-analysis. J Invest Allergol Clin Immunol 2005 : 15 : 9 16.
49. Reider N. Sublingual immunotherapy for allergic rhinoconjunctivitis - the seeming and the real. Int Arch Allergy Immunol 2005 : 137 : 181 6.
50. Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 : 108 : S147 334.